Antisense oligonucleotide inhibitors of isozymes of protein kinase C: in vitro and in vivo activity, and clinical development as anti-cancer therapeutics.

K McGraw, Dean Nm, Loren Miraglia et al.|PubMed|1997

Cited by 22